UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 22, 2026
Sale
Calculated transaction value
$1.02M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 21, 2026
Public filing date
Jul 22, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$535.83
Jul 21, 2026
Close before public filing
$535.83
Jul 21, 2026
Return since public filing
-9.0%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,926 shares @ $530.5
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000103
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.34M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 21, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $126.59K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $269.54K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $1.38M |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $191.69K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $341.49K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $940.92K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $182.59K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $450.02K |
| United Therapeutics Corp UTHR Current | Sale | Jul 21, 2026 | $1.02M |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $62.92K |
| United Therapeutics Corp UTHR | Sale | Jul 21, 2026 | $84.2K |
| United Therapeutics Corp UTHR | Exercise | Jul 21, 2026 | $0 |